SMTL ID : 4ach.1

GSK3b in complex with inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

homo-dimer

Ligands

2 x KDI: 3-AMINO-N-(3-METHOXYPROPYL)-6-{4-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}PYRAZINE-2-CARBOXAMIDE(Non-covalent)

KDI.1: 16 residues within 4Å: Chain A: I.107, V.115, A.128, V.155, L.177, D.178, Y.179, V.180, P.181, E.182, T.183, R.186, Q.230, L.233, C.244, D.245 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:I.107, A:T.183, A:D.245 Hydrogen bonds: A:D.178, A:V.180 KDI.2: 14 residues within 4Å: Chain B: I.107, A.128, V.155, L.177, D.178, Y.179, V.180, P.181, E.182, T.183, R.186, Q.230, L.233, C.244 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:I.107, B:T.183, B:L.233 Hydrogen bonds: B:D.178, B:V.180, B:R.186 Water bridges: B:D.245

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Berg, S. et al., Discovery of novel potent and highly selective glycogen synthase kinase-3 beta (GSK3 beta ) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines. J. Med. Chem. (2012)

Release Date

2012-05-16

Peptides

GLYCOGEN SYNTHASE KINASE-3 BETA: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

GLYCOGEN SYNTHASE KINASE-3 BETA

Related Entries With Identical Sequence